A Bayesian weighted quasi-likelihood design for phase I/II clinical trial with repeated dose administration in preterm newborns

被引：0
|
作者：
Ursino, Moreno [1 ]
Yuan, Ying [2 ]
Alberti, Corinne [3 ]
Comets, Emmanuelle [4 ,5 ]
Friede, Tim [6 ]
Lents, Frederike [7 ]
Stallard, Nigel [8 ]
Zohar, Sarah [1 ]
机构：
[1] INSERM, UMRS1138, Team22, Paris, France
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] INSERM, UMR 1123, Paris, France
[4] INSERM, CIC 1414, Paris, France
[5] INSERM IAME, UMR 1137, Paris, France
[6] Univ Med Ctr Gottingen, Gottingen, Germany
[7] Fed Inst Drugs & Med Devices, Bonn, Germany
[8] Univ Warwick, Warwick Med Sch, Warwick, England
来源：
TRIALS | 2017年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
P343
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Bayesian quasi-likelihood design for identifying the minimum effective dose and maximum utility dose in dose-ranging studies
    Tian, Feng
    Lin, Ruitao
    Wang, Li
    Yuan, Ying
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2024, 33 (06) : 931 - 944
  • [2] A Bayesian phase I-II clinical trial design to find the biological optimal dose on drug combination
    Wang, Ziqing
    Zhang, Jingyi
    Xia, Tian
    He, Ruyue
    Yan, Fangrong
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2024, 34 (04) : 582 - 595
  • [3] A Bayesian phase I/II clinical trial design in the presence of informative dropouts
    Guo, Beibei
    Zang, Yong
    Yuan, Ying
    STATISTICS AND ITS INTERFACE, 2015, 8 (02) : 217 - 226
  • [4] A Bayesian Phase I/II Trial Design for Immunotherapy
    Liu, Suyu
    Guo, Beibei
    Yuan, Ying
    JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2018, 113 (523) : 1016 - 1027
  • [5] A robust Bayesian dose-finding design for phase I/II clinical trials
    Liu, Suyu
    Johnson, Valen E.
    BIOSTATISTICS, 2016, 17 (02) : 249 - 263
  • [6] Bayesian phase II clinical trial design with noncompliance
    Ren, Tingyang
    Shen, Weining
    Zhang, Liwen
    Zhao, Haibing
    STATISTICS IN MEDICINE, 2021, 40 (20) : 4457 - 4472
  • [7] A Bayesian dose-finding design for phase I/II clinical trials with nonignorable dropouts
    Guo, Beibei
    Yuan, Ying
    STATISTICS IN MEDICINE, 2015, 34 (10) : 1721 - 1732
  • [8] Bayesian adaptive model selection design for optimal biological dose finding in phase I/II clinical trials
    Lin, Ruitao
    Yin, Guosheng
    Shi, Haolun
    BIOSTATISTICS, 2023, 24 (02) : 277 - 294
  • [9] Phase I and II clinical trial design for targeted agents
    Richard L. Schilsky
    Targeted Oncology, 2006, 1 : 220 - 227
  • [10] Phase I and II clinical trial design for targeted agents
    Schilsky, Richard L.
    TARGETED ONCOLOGY, 2006, 1 (04) : 220 - 227
12345